CRKL up‐regulation potentially promotes hepatocarcinogenesis via enhancing cancer cells’ glucose metabolism through increasing GLUT1 expression, potentiating HKII activity and inactivating GSK3β activity. This evidence concerns the gene SLC2A1 and cancer.